Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07349537
Phase 1, Recruiting
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for
Breast Atypical Ductal Hyperplasia,
Location: Boston MA, Cleveland OH, Ann Arbor MI, Charleston SC,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18 - 55
Code: NCT06184750
Phase 2, Recruiting
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
for
Melanoma, Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, Richmond VA
Sponsor: IO Biotech
Sex: All
Age: 18+
Code: NCT05280314
Phase 2, Recruiting
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
for
Glioblastoma, GBM
Location: Boston MA, Albany NY, New York NY, Long Island City NY,
Sponsor: Alpheus Medical, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07225621
Phase 2, Recruiting
Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
for
Succinic Semialdehyde Dehydrogenase Deficiency
Location: Boston MA
Sponsor: Boston Children's Hospital
Sex: All
Age: 0+
Code: NCT03758521
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06311214
Phase 2, Recruiting
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)